Ubtech Robotics’ U1 Consumer Robot Draws 13,000+ Pre-Orders, Yet Shares Slide on Profit Fears

Chinese robotics firm Ubtech pivots to mass market with ¥990,000 companion robot, but faces skepticism, heavy losses, and growing competition from profitable rival Unitree.

Ubtech Robotics is trying to do something no Chinese robotics company has yet pulled off: pivot from a successful industrial humanoid business into the mass consumer market without blowing a hole in its balance sheet. The market, for now, is betting against it. The stock ended Thursday at €10.50 in Frankfurt, down 15% over the past 30 days and 38% below its January high of €17.00. A single session earlier in the week saw a 9.68% plunge to €10.75, wiping out most of the gains triggered by the launch of the UWORLD U1 series.

The U1 is a ultra-bionic humanoid designed as an emotional companion for home use, priced at up to ¥990,000. At the June 30 launch event, the company logged more than 13,361 pre?orders on the first day alone. BofA Securities later cited 13,400 orders as of that date, raising its price target to 162 Hong Kong dollars and boosting revenue forecasts for 2026–2028 by 15%–20%. Deliveries are scheduled to begin in September, with an international rollout planned for next year.

But underneath the headline surge lies a much tougher story. Ubtech has never recorded a profit. Its net loss in the last fiscal year came in at about ¥703 million, though that was a 32% improvement over the prior year. BofA expects the loss to narrow to ¥209 million in 2026 and flip to profit in 2027. Over the past five years, the company has burned through nearly ¥5 billion. The consumer pivot adds new costs: mass?producing a ¥990,000 companion robot for private households, while simultaneously scaling industrial humanoid output to 10,000 units annually by 2026.

That industrial side remains the stronger leg. Revenue from full?size humanoids for factory use surged 2,204% year?on?year in 2025, making it the company’s biggest revenue driver. A partnership with Siemens Industrial Software, inked in March, aims to digitise manufacturing and move toward mass production. Since May, Ubtech has been in a verification phase with Hitachi China for joint development of intelligent factory solutions. As volumes rise, management projects annual cost reductions of 20%–30%. The CEO argues that humanoids will take over most physical and repetitive work over the next two decades, driven by labour shortages.

The risk is that the consumer push overshadows that progress. Chinese media have questioned whether the U1 Ultra’s price tag is realistic for the target audience, and whether the “companion” concept is a sound bet on the loneliness economy or a narrative that has lost touch with purchasing power. Competition is also tightening. On June 1, Unitree Robotics received Shanghai Stock Exchange approval for an IPO on the STAR Market, raising ¥4.2 billion. Unitree delivered more than 5,500 humanoids in 2025 and turned profitable in the same year—a milestone Ubtech has yet to reach.

Despite the scepticism, major banks remain constructive. JPMorgan lifted its price target to 161 Hong Kong dollars, citing a sharply revised upward delivery forecast for advanced humanoids. The stock’s 50?day moving average of €11.96—now €10.12 above the current price—reflects how far momentum has reversed. With annualised volatility of nearly 78% and a relative strength index of 41 (after stabilising from an earlier 42.8), the shares sit in neutral territory, closer to their 52?week low of €9.42 than to the high.

What comes next hinges on execution. Ubtech must prove that pre?orders can translate into real deliveries from September—a far harder test than collecting refundable deposits. The partnerships with Siemens and Hitachi need to show progress on cost and capacity targets. If both tracks stay on course, the risk?reward profile could tilt upward. If consumer demand stalls or factory ramp?ups slip, the downward pressure of recent months is likely to persist. The quarterly reports on production volumes, cost structure and actual market penetration of the U1 will decide which narrative wins.